Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Icu Medical (ICUI) over the last 14 years, with Q3 2025 value amounting to $2.7 million.

  • Icu Medical's Change in Intangibles fell 961.73% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 604.71%. This contributed to the annual value of $10.8 million for FY2024, which is 1080.09% up from last year.
  • Per Icu Medical's latest filing, its Change in Intangibles stood at $2.7 million for Q3 2025, which was down 961.73% from $2.3 million recorded in Q2 2025.
  • Over the past 5 years, Icu Medical's Change in Intangibles peaked at $6.1 million during Q3 2021, and registered a low of $1.9 million during Q1 2021.
  • In the last 5 years, Icu Medical's Change in Intangibles had a median value of $2.4 million in 2024 and averaged $2.6 million.
  • In the last 5 years, Icu Medical's Change in Intangibles surged by 17375.06% in 2021 and then plummeted by 6513.16% in 2022.
  • Over the past 5 years, Icu Medical's Change in Intangibles (Quarter) stood at $2.4 million in 2021, then increased by 1.95% to $2.5 million in 2022, then decreased by 17.21% to $2.0 million in 2023, then rose by 23.64% to $2.5 million in 2024, then rose by 6.08% to $2.7 million in 2025.
  • Its Change in Intangibles stands at $2.7 million for Q3 2025, versus $2.3 million for Q2 2025 and $2.2 million for Q1 2025.